Orchid Pharma Limited (NSE:ORCHPHARMA)

Market Cap	42.78B
Revenue (ttm)	9.02B
Net Income (ttm)	1.11B
Shares Out	50.72M
EPS (ttm)	21.87
PE Ratio	38.58
Forward PE	32.17
Dividend	n/a
Ex-Dividend Date	n/a

Volume	107,819
Average Volume	111,905
Open	812.00
Previous Close	811.20
Day's Range	812.00 - 850.90
52-Week Range	684.35 - 1,997.40
Beta	1.96
RSI	48.17
Earnings Date	May 30, 2025

About Orchid Pharma

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company has multi-therapeutic presence in anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile product...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1992
• Employees: 871
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ORCHPHARMA

Financial Performance

In 2023, Orchid Pharma's revenue was 8.19 billion, an increase of 23.05% compared to the previous year's 6.66 billion. Earnings were 921.67 million, an increase of 98.99%.